Cargando…
Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis
Pulmonary sarcoidosis is characterized by an exaggerated CD4(+) T cell response and formation of non‐necrotizing granulomas. Tumour necrosis factor α (TNF‐α) is regarded as crucial for granuloma formation and TNF‐α inhibitors offer a third‐line treatment option for patients not responding to convent...
Autores principales: | Kullberg, S., Rivera, N. V., Abo Al Hayja, M., Grunewald, J., Eklund, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290087/ https://www.ncbi.nlm.nih.gov/pubmed/32275772 http://dx.doi.org/10.1111/cei.13438 |
Ejemplares similares
-
Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types
por: Abo Al Hayja, Muntasir, et al.
Publicado: (2023) -
Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
por: Kullberg, Susanna, et al.
Publicado: (2021) -
Reduced expression of peroxisome proliferator-activated receptor alpha in BAL and blood T cells of non-löfgren’s sarcoidosis patients
por: Abo Al Hayja, Muntasir, et al.
Publicado: (2015) -
No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis
por: Wikén, Maria, et al.
Publicado: (2010) -
High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells
por: Kullberg, Susanna, et al.
Publicado: (2020)